Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
[11C]carfentanil is a radiolabeled version of carfentanil, a highly potent synthetic opioid. It is used as a radiotracer in positron emission tomography (PET) imaging to visualize and quantify mu-opioid receptor (MOR) expression in the brain and body. With a sub-nanomolar affinity (Ki of 0.024 nM) and high selectivity for the mu-opioid receptor, it has been used for decades to study MOR behavior in humans, non-human primates, and rodents. The radiotracer has been instrumental in advancing understanding of MOR pharmacology, pain mechanisms, and various pathological conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on [11C]carfentanil.